vs
Sol-Gel Technologies Ltd.（SLGL）与泛美白银（USAS）财务数据对比。点击上方公司名可切换其他公司
泛美白银的季度营收约是Sol-Gel Technologies Ltd.的1.1倍（$19.1M vs $17.3M），Sol-Gel Technologies Ltd.净利率更高（67.3% vs -82.3%，领先149.6%），Sol-Gel Technologies Ltd.同比增速更快（217.7% vs -28.0%）
Sol-Gel Technologies Ltd.是一家专注皮肤科药物研发的专业生物制药企业，依托专有溶胶凝胶递送技术开发痤疮、玫瑰痤疮、特应性皮炎等常见皮肤疾病的外用治疗方案，核心市场覆盖北美与欧洲，与医疗行业知名企业合作推进产品商业化。
泛美白银是一家总部位于加拿大的矿业企业，业务布局集中在拉丁美洲，在墨西哥、秘鲁、玻利维亚、阿根廷多国持有运营矿山及其他矿产开发项目，是美洲地区重要的贵金属开采企业。
SLGL vs USAS — 直观对比
营收规模更大
USAS
是对方的1.1倍
$17.3M
营收增速更快
SLGL
高出245.7%
-28.0%
净利率更高
SLGL
高出149.6%
-82.3%
损益表 — Q2 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $17.3M | $19.1M |
| 净利润 | $11.6M | $-15.7M |
| 毛利率 | — | 34.2% |
| 营业利润率 | 65.1% | — |
| 净利率 | 67.3% | -82.3% |
| 营收同比 | 217.7% | -28.0% |
| 净利润同比 | 487.6% | 2.8% |
| 每股收益（稀释后） | $4.17 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SLGLUSAS
| Q3 25 | — | $19.1M | ||
| Q2 25 | $17.3M | — | ||
| Q3 24 | — | $26.5M | ||
| Q2 24 | $5.4M | — | ||
| Q2 23 | $594.0K | — | ||
| Q2 22 | $3.5M | — |
净利润SLGLUSAS
| Q3 25 | — | $-15.7M | ||
| Q2 25 | $11.6M | — | ||
| Q3 24 | — | $-16.2M | ||
| Q2 24 | $2.0M | — | ||
| Q2 23 | $-6.0M | — | ||
| Q2 22 | $-134.0K | — |
毛利率SLGLUSAS
| Q3 25 | — | 34.2% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | 23.6% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
营业利润率SLGLUSAS
| Q3 25 | — | — | ||
| Q2 25 | 65.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 29.9% | — | ||
| Q2 23 | -1098.8% | — | ||
| Q2 22 | -13.2% | — |
净利率SLGLUSAS
| Q3 25 | — | -82.3% | ||
| Q2 25 | 67.3% | — | ||
| Q3 24 | — | -60.9% | ||
| Q2 24 | 36.4% | — | ||
| Q2 23 | -1005.1% | — | ||
| Q2 22 | -3.8% | — |
每股收益（稀释后）SLGLUSAS
| Q3 25 | — | — | ||
| Q2 25 | $4.17 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.71 | — | ||
| Q2 23 | $-0.22 | — | ||
| Q2 22 | $0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.3M | $39.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $31.9M | $50.2M |
| 总资产 | $39.3M | $234.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SLGLUSAS
| Q3 25 | — | $39.1M | ||
| Q2 25 | $24.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $26.5M | — | ||
| Q2 23 | $33.5M | — | ||
| Q2 22 | $15.6M | — |
股东权益SLGLUSAS
| Q3 25 | — | $50.2M | ||
| Q2 25 | $31.9M | — | ||
| Q3 24 | — | $53.1M | ||
| Q2 24 | $34.9M | — | ||
| Q2 23 | $48.3M | — | ||
| Q2 22 | $50.4M | — |
总资产SLGLUSAS
| Q3 25 | — | $234.7M | ||
| Q2 25 | $39.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $42.0M | — | ||
| Q2 23 | $55.1M | — | ||
| Q2 22 | $55.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-12.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-41.3M |
| 自由现金流率自由现金流/营收 | — | -216.5% |
| 资本支出强度资本支出/营收 | — | 150.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流SLGLUSAS
| Q3 25 | — | $-12.5M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | — | ||
| Q2 23 | $-8.3M | — | ||
| Q2 22 | — | — |
自由现金流SLGLUSAS
| Q3 25 | — | $-41.3M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $-11.2M | ||
| Q2 24 | — | — | ||
| Q2 23 | $-8.4M | — | ||
| Q2 22 | — | — |
自由现金流率SLGLUSAS
| Q3 25 | — | -216.5% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | -42.2% | ||
| Q2 24 | — | — | ||
| Q2 23 | -1419.0% | — | ||
| Q2 22 | — | — |
资本支出强度SLGLUSAS
| Q3 25 | — | 150.8% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | — | ||
| Q2 23 | 15.8% | — | ||
| Q2 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
